|
Volumn 365, Issue 6, 2011, Pages 568-569
|
Early prostate cancer - Treat or watch? [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
AGE;
EARLY CANCER;
EARLY DIAGNOSIS;
HUMAN;
LETTER;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATE HYPERTROPHY;
PROSTATECTOMY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SYMPTOM;
TREATMENT INDICATION;
AGED;
EPIDEMIOLOGY;
MALE;
METHODOLOGY;
MIDDLE AGED;
NOTE;
PROSTATE TUMOR;
WATCHFUL WAITING;
CANCER MORTALITY;
CANCER SCREENING;
DIGITAL RECTAL EXAMINATION;
ERECTILE DYSFUNCTION;
HEALTH CARE COST;
METASTASIS;
PROGNOSIS;
RISK ASSESSMENT;
URINE INCONTINENCE;
BLOOD;
MORTALITY;
AGE FACTORS;
AGED;
HUMANS;
MALE;
MIDDLE AGED;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
SELECTION BIAS;
WATCHFUL WAITING;
PROSTATE-SPECIFIC ANTIGEN;
|
EID: 80051635953
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1106325 Document Type: Letter |
Times cited : (11)
|
References (1)
|